Mårten Segelmark
61 – 70 of 204
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Coding practice in national and regional kidney biopsy registries
- Contribution to journal › Article
-
Mark
Treatment practices and outcomes in incident peritoneal dialysis patients : The Swedish Renal Registry 2006-2015
- Contribution to journal › Article
- 2020
-
Mark
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
- Contribution to journal › Scientific review
-
Mark
Incidence and predictors of severe infections in ANCA-associated vasculitis in a population-based cohort – preliminary results
- Contribution to journal › Published meeting abstract
-
Mark
International consensus on antineutrophil cytoplasm antibodies testing in eosinophilic granulomatosis with polyangiitis
- Contribution to journal › Article
-
Mark
Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic
- Contribution to journal › Article
-
Mark
Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
- Contribution to journal › Article
-
Mark
2020 international consensus on ANCA testing beyond systemic vasculitis
- Contribution to journal › Scientific review
-
Mark
Serum levels and removal by haemodialysis and haemodiafiltration of tryptophan-derived uremic toxins in ESKD patients
- Contribution to journal › Article
-
Mark
Serological testing in small vessel vasculitis
- Contribution to journal › Scientific review
